Unit

Laboratory for Biomedical Microfluidics

Laboratory
Summary

The Biomedical Microfluid Laboratory (LBMM) at EPFL focuses on developing innovative approaches for drug discovery and personalized cancer therapy. With a strong translational focus, LBMM collaborates with the pharma industry, promotes entrepreneurship, and facilitates the transition of research results into clinical trials. The lab's interdisciplinary team includes experts from biology, genomics, bioinformatics, engineering, and physics. Using microscopic droplets as miniaturized reaction vessels, LBMM achieves significantly increased throughput, performs screens on the single-cell level, and minimizes sample consumption. Research themes include therapeutic antibodies and T-cells, personalized medicine, genomics, and continuous development of microfluidic technology.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.